Advances in Microbial Biosynthesis of Plant Natural Products

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biochemical Engineering".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 1469

Special Issue Editors


E-Mail Website
Guest Editor
State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
Interests: metabolic engineering; synthetic biology; microbial cell factories; plant natural products; tolerance engineering

E-Mail Website
Guest Editor
Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China
Interests: natural products; synthetic biology; metabolic engineering; enzymology; bioorganic chemistry

E-Mail Website
Guest Editor
Key Laboratory of Human Microenvironment and Precision Medicine of Anhui Higher Education Institutes, School of Life Sciences, Anhui University, Hefei 230601, China
Interests: natural products; synthetic biology; microbial cell factories; bioconversion; protein engineering

Special Issue Information

Dear Colleagues,

Plant drugs have been used for thousands of years to treat various diseases, and they have contributed to the development of numerous modern medicines. Plant natural products (PNPs), which include terpenoids, alkaloids, polyketides, and phenylpropanoids, are an important family of compounds with numerous attractive activities, such as antioxidation, antitumor, anti-inflammatory, and analgesic properties. PNPs are widely used in medicine, cosmetics, health products, condiments, pigments, and other high-value fields. Traditionally, PNPs are mainly extracted from wild and/or cultivated plants, but this route suffers from obvious disadvantages, such as low yield, high cost, and fluctuating supply. However, the flourishing synthetic biology in recent years provides a new route for the biosynthesis of PNPs in microbial hosts.

By elucidating the pathway and discovering the key enzymes of PNP biosynthesis, synthetic biology strategies can be employed to build microbial cell factories to produce PNPs or PNP intermediates. These cell factories can continuously and efficiently synthesize low-carbon, economic, and environmentally friendly PNPs, which will provide an alternative approach to the current route of plant extraction. The performance of PNPs microbial cell factories can be further improved by mining and/or engineering key pathway enzymes, increasing substrate import, enhancing cofactors’ supply, minimizing byproducts’ formation, alleviating metabolic burden, accelerating product export, and so on. Enzyme engineering and artificial biosynthetic route construction can also be used to create novel PNP derivatives.

The scope of this Special Issue is to address the potential and challenges to achieve efficient synthesis of various PNPs in microbial cells. This Special Issue will cover topics related to the microbial cell factory, plant natural products, bioactive compounds, synthetic biology, metabolic engineering, metabolic regulation, metabolic pathway, and microbial fermentation. These studies will help researchers and engineers to make use of various metabolic research strategies, achieving the goal of cost-effective microbial production of PNPs.

Dr. Zaigao Tan
Dr. Tao Liu
Dr. Wei Zhou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • microbial cell factory
  • plant natural products
  • bioactive compounds
  • synthetic biology
  • metabolic engineering
  • metabolic regulation
  • metabolic pathway
  • microbial fermentation

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 3224 KiB  
Article
Production of Astaxanthin Using CBFD1/HFBD1 from Adonis aestivalis and the Isopentenol Utilization Pathway in Escherichia coli
by Jared H. Roth and Valerie C. A. Ward
Bioengineering 2023, 10(9), 1033; https://doi.org/10.3390/bioengineering10091033 - 01 Sep 2023
Viewed by 1222
Abstract
Astaxanthin is a powerful antioxidant and is used extensively as an animal feed additive and nutraceutical product. Here, we report the use of the β-carotene hydroxylase (CBFD1) and the β-carotene ketolase (HBFD1) from Adonis aestivalis, a flowering plant, to produce astaxanthin in [...] Read more.
Astaxanthin is a powerful antioxidant and is used extensively as an animal feed additive and nutraceutical product. Here, we report the use of the β-carotene hydroxylase (CBFD1) and the β-carotene ketolase (HBFD1) from Adonis aestivalis, a flowering plant, to produce astaxanthin in E. coli equipped with the P. agglomerans β-carotene pathway and an over-expressed 4-methylerythritol-phosphate (MEP) pathway or the isopentenol utilization pathway (IUP). Introduction of the over-expressed MEP pathway and the IUP resulted in a 3.2-fold higher carotenoid content in LB media at 36 h post-induction compared to the strain containing only the endogenous MEP. However, in M9 minimal media, the IUP pathway dramatically outperformed the over-expressed MEP pathway with an 11-fold increase in total carotenoids produced. The final construct split the large operon into two smaller operons, both with a T7 promoter. This resulted in slightly lower productivity (70.0 ± 8.1 µg/g·h vs. 53.5 ± 3.8 µg/g·h) compared to the original constructs but resulted in the highest proportion of astaxanthin in the extracted carotenoids (73.5 ± 0.2%). Full article
(This article belongs to the Special Issue Advances in Microbial Biosynthesis of Plant Natural Products)
Show Figures

Figure 1

Back to TopTop